A fresh report titled “ Hormonal Contraceptive Market ” has been presented by KD market research. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for Hormonal Contraceptive Market . The competition analysis is also a major part of the report.
The global hormonal contraceptive market was valued at $13,924 million in 2016, and is estimated to reach $16,018 million by 2023, registering a CAGR of 1.9% from 2017 to 2023. Hormonal contraception is a birth control method, which acts on the endocrine system, and is composed of steroid hormones. Higher concentration of naturally forming hormones such as estrogen and progesterone are used to either prevent ovulation or make unfavorable condition to develop pregnancy.
Request Sample Copy of this Report @ https://www.kdmarketresearch.com/sample/3367
Increase in adoption of hormonal contraceptives products or birth control methods in the developing countries and incidence of polycystic ovary syndrome (PCOS) are the major driving factors for the growth of the global hormonal contraceptive market. Moreover, rise in population attaining higher education and rise in need to control the ever-growing population in developing regions such as China and India have adopted measures to prevent unwanted pregnancy, which are expected to fuel the market growth. However, availability of alternate contraceptive methods and health risks associated with the use of contraceptives hamper the market growth.
The global hormonal contraceptive market is segmented on the basis of product, hormone, age group, end user, and geography. Based on product, the market is classified into oral contraceptive pills, injectable birth control, emergency contraceptive pills, vaginal rings, and transdermal patches. Depending on hormone, it is bifurcated into progestin-only contraceptive and combined hormonal contraceptive. By age group, it is categorized into 15?24 years, 25?34 years, 35?44 years, and above 44 years. By end user, it is classified into hospitals, household, and clinics. Geographically, it is analyzed across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STAKEHOLDERS
-This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
-The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
-In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
-The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Product
-Oral Contraceptive Pills
-Injectable Birth Control
-Emergency Contraceptive Pills
-Vaginal Rings
-Transdermal Patches
By Hormone
-Progestin-only Contraceptive
-Combined Hormonal Contraceptive
By Age Group
-15?24 Years
-25?34 Years
-35?44 Years
-Above 44 Years
By End User
-Hospitals
-Household
-Clinics
By Region
-North America
-U.S.
-Canada
-Mexico
-Europe
-Germany
-UK
-France
-Spain
-Italy
-Rest of Europe
-Asia-Pacific
-Japan
-China
-Australia
-India
-South Korea
-Rest of Asia-Pacific
-LAMEA
-Brazil
-Saudi Arabia
-South Africa
-Rest of LAMEA
KEY PLAYERS PROFILED
-The Female Health Company
-Teva Pharmaceutical Industries Limited
-Bayer AG
-Pfizer, Inc.
-Mylan N.V.
-Johnson & Johnson
-Ansell Ltd.
-Mayer Laboratories
-Merck & Co., Inc.
-Church & Dwight, Co., Inc.
The other players of the hormonal contraceptive market include (companies not profiled in the report):
-Reckitt Benckiser Plc.
-Warner Chilcott Company
-BioSante Pharmaceuticals Inc.
-HLL Lifecare Limited
-Boehringer Ingelheim GmbH
-Watson Pharmaceuticals, Inc.
-V-Care Pharma Pvt. Ltd.
-Vardhman Life Care Pvt. Ltd.
-Cipla Limited
Browse Full Research Report with toc@ https://www.kdmarketresearch.com/report/3367/hormonal-contraceptive-market-amr
Table of Content
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.3. Top Player Positioning, 2016
3.4. Porters Five Forces Analysis
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Rise in need for preventing unwanted pregnancy
3.5.1.2. Increasing awareness for contraceptives worldwide
3.5.1.3. Rising usage of oral contraceptives as a preferred method to avoid unplanned pregnancy
3.5.1.4. Technological advancements in contraceptive methods
3.5.1.5. Upsurge in government and NGO initiatives promoting contraceptives
3.5.2. Restrains
3.5.2.1. Health risks associated with the use of contraceptive methods
3.5.2.2. Lack of social acceptance
3.5.3. Opportunities
3.5.3.1. Rise in disposable income and demand for healthy life in emerging economies
3.5.3.2. Presence of large unmet contraceptive needs in emerging Asian and African economies
CHAPTER 4: HORMONAL CONTRACEPTIVE MARKET BY PRODUCT
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Oral Contraceptive Pills
4.2.1. Key market trends & growth opportunities
4.2.2. Market Size and Forecast
4.2.3. Market Analysis, by Country
4.3. Injectable Birth Control
4.3.1. Key market trends & growth opportunities
4.3.2. Market Size and Forecast
4.3.3. Market Analysis, by Country
4.4. Emergency Contraceptive Pills
4.4.1. Key market trends & growth opportunities
4.4.2. Market Size and Forecast
4.4.3. Market Analysis, by Country
4.5. Vaginal Rings
4.5.1. Key market trends & growth opportunities
4.5.2. Market Size and Forecast
4.5.3. Market Analysis, by Country
4.6. Transdermal Patches
4.6.1. Key market trends & growth opportunities
4.6.2. Market Size and Forecast
4.6.3. Market Analysis, by Country
CHAPTER 5: HORMONAL CONTRACEPTIVE MARKET BY HORMONE
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Progestin-only Contraceptive
5.2.1. Market Size and Forecast
5.2.2. Market Analysis, by Country
5.3. Combined Hormonal Contraceptive
5.3.1. Market Size and Forecast
5.3.2. Market Analysis, by Country
CHAPTER 6: HORMONAL CONTRACEPTIVE MARKET BY AGE GROUP
6.1. Overview
6.1.1. Market Size and Forecast
6.2. 15-24 years
6.2.1. Market Size and Forecast
6.2.2. Market Analysis, by Country
6.3. 25-34 years
6.3.1. Market Size and Forecast
6.3.2. Market Analysis, by Country
6.4. 35-44 years
6.4.1. Market Size and Forecast
6.4.2. Market Analysis, by Country
6.5. Above 44 years
6.5.1. Market Size and Forecast
6.5.2. Market Analysis, by Country
CHAPTER 7: HORMONAL CONTRACEPTIVE MARKET BY END USERS
7.1. Overview
7.1.1. Market Size and Forecast
7.2. Hospitals
7.2.1. Market Size and Forecast
7.2.2. Market Analysis, by Country
7.3. Household
7.3.1. Market Size and Forecast
7.3.2. Market Analysis, by Country
7.4. Clinics
7.4.1. Market Size and Forecast
7.4.2. Market Analysis, by Country
CHAPTER 8: HORMONAL CONTRACEPTIVE MARKET BY GEOGRAPHY
8.1. Overview
8.1.1. Market Size and Forecast
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, by Product Type
8.2.3. Market Size and Forecast, by Hormone
8.2.4. Market Size and Forecast, by Age Group
8.2.5. Market Size and Forecast, by End Users
8.2.6. Market Size and Forecast, by Country
8.2.6.1. U.S. Market Size and Forecast, by Product Type
8.2.6.2. U.S. Market Size and Forecast, by Hormone
8.2.6.3. U.S. Market Size and Forecast, by Age Group
8.2.6.4. U.S. Market Size and Forecast, by End Users
8.2.6.5. Canada Market Size and Forecast, by Product Type
8.2.6.6. Canada Market Size and Forecast, by Hormone
8.2.6.7. Canada Market Size and Forecast, by Age Group
8.2.6.8. Canada Market Size and Forecast, by End Users
8.2.6.9. Mexico Market Size and Forecast, by Product Type
8.2.6.10. Mexico Market Size and Forecast, by Hormone
8.2.6.11. Mexico Market Size and Forecast, by Age Group
8.2.6.12. Mexico Market Size and Forecast, by End Users
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, by Product Type
8.3.3. Market Size and Forecast, by Hormone
8.3.4. Market Size and Forecast, by Age Group
8.3.5. Market Size and Forecast, by End Users
8.3.6. Market Size and Forecast, by Country
8.3.6.1. Germany Market Size and Forecast, by Product Type
8.3.6.2. Germany Market Size and Forecast, by Hormone
8.3.6.3. Germany Market Size and Forecast, by Age Group
8.3.6.4. Germany Market Size and Forecast, by End Users
8.3.6.5. France Market Size and Forecast, by Product Type
8.3.6.6. France Market Size and Forecast, by Hormone
8.3.6.7. France Market Size and Forecast, by Age Group
8.3.6.8. France Market Size and Forecast, by End Users
8.3.6.9. UK Market Size and Forecast, by Product Type
8.3.6.10. UK Market Size and Forecast, by Hormone
8.3.6.11. UK Market Size and Forecast, by Age Group
8.3.6.12. UK Market Size and Forecast, by End Users
8.3.6.13. Italy Market Size and Forecast, by Product Type
8.3.6.14. Italy Market Size and Forecast, by Hormone
8.3.6.15. Italy Market Size and Forecast, by Age Group
8.3.6.16. Italy Market Size and Forecast, by End Users
8.3.6.17. Spain Market Size and Forecast, by Product Type
8.3.6.18. Spain Market Size and Forecast, by Hormone
8.3.6.19. Spain Market Size and Forecast, by Age Group
8.3.6.20. Spain Market Size and Forecast, by End Users
8.3.6.21. Rest of Europe Market Size and Forecast, by Product Type
8.3.6.22. Rest of Europe Market Size and Forecast, by Hormone
8.3.6.23. Rest of Europe Market Size and Forecast, by Age Group
8.3.6.24. Rest of Europe Market Size and Forecast, by End Users
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, by Product Type
8.4.3. Market Size and Forecast, by Hormone
8.4.4. Market Size and Forecast, by Age Group
8.4.5. Market Size and Forecast, by End Users
8.4.6. Market Size and Forecast, by Country
8.4.6.1. Japan Market Size and Forecast, by Product Type
8.4.6.2. Japan Market Size and Forecast, by Hormone
8.4.6.3. Japan Market Size and Forecast, by Age Group
8.4.6.4. Japan Market Size and Forecast, by End Users
8.4.6.5. China Market Size and Forecast, by Product Type
8.4.6.6. China Market Size and Forecast, by Hormone
8.4.6.7. China Market Size and Forecast, by Age Group
8.4.6.8. China Market Size and Forecast, by End Users
8.4.6.9. Australia Market Size and Forecast, by Product Type
8.4.6.10. Australia Market Size and Forecast, by Hormone
8.4.6.11. Australia Market Size and Forecast, by Age Group
8.4.6.12. Australia Market Size and Forecast, by End Users
8.4.6.13. India Market Size and Forecast, by Product Type
8.4.6.14. India Market Size and Forecast, by Hormone
8.4.6.15. India Market Size and Forecast, by Age Group
8.4.6.16. India Market Size and Forecast, by End Users
8.4.6.17. South Korea Market Size and Forecast, by Product Type
8.4.6.18. South Korea Market Size and Forecast, by Hormone
8.4.6.19. South Korea Market Size and Forecast, by Age Group
8.4.6.20. South Korea Market Size and Forecast, by End Users
8.4.6.21. Rest of Asia-Pacific Market Size and Forecast, by Product Type
8.4.6.22. Rest of Asia-Pacific Market Size and Forecast, by Hormone
8.4.6.23. Rest of Asia-Pacific Market Size and Forecast, by Age Group
8.4.6.24. Rest of Asia-Pacific Market Size and Forecast, by End Users
8.5. LAMEA
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, by Product Type
8.5.3. Market Size and Forecast, by Hormone
8.5.4. Market Size and Forecast, by Age Group
8.5.5. Market Size and Forecast, by End Users
8.5.6. Market Size and Forecast, by Country
8.5.6.1. Brazil Market Size and Forecast, by Product Type
8.5.6.2. Brazil Market Size and Forecast, by Hormone
8.5.6.3. Brazil Market Size and Forecast, by Age Group
8.5.6.4. Brazil Market Size and Forecast, by End Users
8.5.6.5. Saudi Arabia Market Size and Forecast, by Product Type
8.5.6.6. Saudi Arabia Market Size and Forecast, by Hormone
8.5.6.7. Saudi Arabia Market Size and Forecast, by Age Group
8.5.6.8. Saudi Arabia Market Size and Forecast, by End Users
8.5.6.9. South Africa Market Size and Forecast, by Product Type
8.5.6.10. South Africa Market Size and Forecast, by Hormone
8.5.6.11. South Africa Market Size and Forecast, by Age Group
8.5.6.12. South Africa Market Size and Forecast, by End Users
8.5.6.13. Rest of LAMEA Market Size and Forecast, by Product Type
8.5.6.14. Rest of LAMEA Market Size and Forecast, by Hormone
8.5.6.15. Rest of LAMEA Market Size and Forecast, by Age Group
8.5.6.16. Rest of LAMEA Market Size and Forecast, by End Users
CHAPTER 9: COMPANY PROFILES
9.1. Ansell Limited
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.2. Bayer AG
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments
9.3. Church & Dwight Co. Inc.
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.4. Johnson & Johnson
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.5. Mayer Laboratories Inc.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.6. Merck & Co. Inc.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.7. Mylan N.V.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments
9.8. Pfizer Inc.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments
9.9. Teva Pharmaceutical Industries Ltd.
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments
9.10. The Female Health Company
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Business performance”
Check Exclusive Discount on this Report @ https://www.kdmarketresearch.com/discount/3367
About Us:
KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.
Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.
Contact us -
KD Market Research
150 State Street, Albany,
New York, USA 12207
Website: www.kdmarketresearch.com
Email id- sales@kdmarketresearch.com
More - https://kdmarketresearch.blogspot.com/
No comments:
Post a Comment